Subscribe to one of our feedsfont size
Business
- The Bulls Strike Back
Podcast: July 3, 2009 - Summer Sizzle
A hot week for biotech dealmaking as Roche aligns itself with BIO. - Ending Another Kind of Drug Trade
Regulators seek to end settlements that let brand-name pharmaceutical makers pay generic competitors to stay out of the market.
Health
- Suppressing the Suppressor
Researchers pinpoint a new enemy for tumor-suppressor p53. - Time for Hard Choices
Two top U.S. researchers say the medical community must address the dilemma of using expensive treatments that only extend life for a short while. - Waging a War on Smoking
The U.S. government should take stronger steps to combat tobacco use in military, veteran populations, says report.
Policy / Law
- Making Comparisons Effective
Any cost-versus-efficiency studies of healthcare should consider at least five elements, researchers say. - How Personalized Medicine Is Transforming Healthcare
Podcast: June 12, 2009 - Inheritance Tax
Individuals with family history of genetic disease are at risk of discrimination.
Society
- Power of Prayer
Novel social history of intercessory prayer studies reveals growing religious diversity and diminishing belief in science to measure the value of prayer. - Ticking Time Bomb
Climate change could trigger a host of environmental disasters by 2050, setting off a wave of massive and disruptive migrations, a new report finds. - Identity Crisis
Cancer drug causes patient to lose fingerprints and be detained by U.S. immigration.
Tech/Innovation
- A Complex Puzzle
Study shows that a combination of common genetic variations can lead to schizophrenia. - A Signature Difference
UCLA researchers find molecular differences between embryonic stem cells and reprogrammed skin cells. - More Pieces of the Autism Puzzle
Further gene mutations linked to risk of the disorder.
Listen to the latest edition from The Journal of Life Sciences
Weekly briefsA round-up of breakthroughs, policy developments and other news reshaping the life sciences landscape.
Thomas Bodenheimer thinks it will not be possible to have successful healthcare reform without addressing the crisis in primary care. Bodenheimer, a professor at the Center for Excellence in Primary Care in the Department of Family and Community Medicine at the University of California, San Francisco recently co-authored a perspective for the New England Journal of Medicine in which he agrues that a comprehensive federal initiative is needed to revitalize primary care in the United States. We spoke to Bodenheimer about why young physicians are not pursuing careers in primary care medicine, why fixing this problem is critical to fixing healthcare, and whether or not the problem is recognized by lawmakers hammering out healthcare reform legislation.
.jpg)
Plenty of executives shook hands last week as a rife of dealmaking swept the life sciences sector. Among those were executives at Johnson & Johnson and Elan Pharmaceuticals, who ended months of rumors as J&J agreed to acquire the rights to Elan's Alzheimer's Immunotherapy Program and make an equity investment in the Ireland-based company. The Alzheimer's program, a partnership with Wyeth through a newly formed J&J company, will initially commit up to $500 million to continue to develop and launch bapineuzumab. The potential first-in-class treatment is being evaluated for slowing the progression of Alzheimer's disease, as well as other compounds.
.jpg)
.gif)
.gif)
- President Pushes Health Plan as an Economic Boon
The New York Times - "Boomeritis" hits aging athletes
Reuters - Heart Stem Cells From Human Embryo ‘Hot Spot’ May Fix Damage
Bloomberg - Suicide Warnings for 2 Anti-Smoking Drugs
The New York Times - Panel Suggests U.S. Medical Priorities
The New York Times - Wal-Mart Says It Backs a Mandate on Insurance
The New York Times - Government moves to staunch massive Medicare fraud
Reuters - Ban Is Advised on 2 Top Pills for Pain Relief
The New York Times - Insured, but Bankrupted by Health Crises
The New York Times - GE teams up with Geron for stem-cell research
Reuters